Industry Research Reports

Home > Reports > Service & Software > Global AI Clinical Endpoint Assessment Software Market Research Report 2026

Global AI Clinical Endpoint Assessment Software Market Research Report 2026

Industry: Service & Software

Published Date: 2026-07-18

Pages: 204 Pages

Report ld: 6977992

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI Clinical Endpoint Assessment Software Market Size(US$)

CAGR 2026-2032

17.6%

Market Size,2032

USD 3,581

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 1,354 million

Market Forecast in 2032(Value)

US$ 3,581 million

CAGR

17.6%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global AI Clinical Endpoint Assessment Software market was valued at US$ 1148 million in 2025 and is anticipated to reach US$ 3581 million by 2032, at a CAGR of 17.6% from 2026 to 2032.

AI clinical endpoint assessment software is specialized software for pharmaceutical, medical device, and digital therapeutic studies that collects, standardizes, and analyzes endpoint data from medical imaging, digital pathology, electronic clinical outcome assessments, wearable sensors, voice or video, and cognitive tasks. It typically applies machine learning, computer vision, signal processing, and natural language processing to quality control, lesion or tissue quantification, scale scoring, digital biomarker computation, central review, and endpoint adjudication, while maintaining audit trails, blinding controls, and regulatory compliance to improve consistency, sensitivity, and reproducibility. The blended gross margin is approximately 72%.

Market growth is driven by clinical trials' need for objective, reproducible, and higher-frequency endpoints. In oncology imaging, neurodegenerative disease, metabolic liver disease, and rare-disease studies, manual reads and rating scales can be affected by inter-reader variability, infrequent visits, and inconsistent site procedures. AI-assisted quantification, central review, and sensor-derived digital endpoints can reduce measurement noise, identify treatment signals earlier, and improve consistency across multicenter studies. Wider use of remote participation and decentralized trials is also increasing demand for electronic clinical outcome assessment, wearable-device, and multimodal endpoint platforms.

Competition is shifting from isolated algorithm performance toward complete evidence-generation capability. Sponsors increasingly evaluate analytical and clinical validation, data integrity, blinding and audit trails, consistency across devices and sites, and integration with EDC, data lakes, and statistical environments. The market is likely to combine platform expansion with specialist differentiation: large vendors will use integrated platforms to cover multiple endpoint types and global delivery, while specialists build higher-sensitivity algorithms and regulatory evidence in neuroimaging, digital pathology, speech, eye tracking, and physiological signals. Stronger regulatory expectations for AI credibility and digital health technologies will raise entry barriers and favor products that support human oversight, explainable outputs, and continuous quality monitoring.

This report delivers a comprehensive overview of the global AI Clinical Endpoint Assessment Software market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding AI Clinical Endpoint Assessment Software. The AI Clinical Endpoint Assessment Software market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global AI Clinical Endpoint Assessment Software market comprehensively. Regional market sizes by Type, by Application, by Automation Level, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist AI Clinical Endpoint Assessment Software manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Clario
Medidata
Signant Health
IQVIA
ICON
Perceptive
Clinical Ink
Koneksa
AiCure
Medable
PathAI
Proscia
Paige
IXICO
Median Technologies
VIDA Diagnostics
Image Analysis Group
QMENTA
Cambridge Cognition
Cogstate
Empatica
Cumulus Neuroscience
Rune Labs
VivoSense
NeuraLight
Aural Analytics
Linus Health
Quibim
Perspectum
Brainomix
Taimei Technology
UnionClin
XincereMed

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Medical Imaging Endpoints
Digital Pathology Endpoints
Electronic Clinical Outcome Assessment
Wearable and Physiological Endpoints
Voice, Video and Cognitive Endpoints
Multimodal Endpoints

Segment by Application

Oncology
Neurology and Psychiatry
Cardiovascular and Metabolic Diseases
Respiratory Diseases
Musculoskeletal and Immunology
Other Therapeutic Areas

Segment by Category

AI Quality Control Only
AI Suggestion with Human Finalization
AI Scoring with Exception Review
Fully Automated AI Scoring

Segment by Division

Data Acquisition Software
Analysis and Scoring Software
Review and Adjudication Software
Integrated Endpoint Platform

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Automation Level, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for AI Clinical Endpoint Assessment Software companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Medical Imaging Endpoints

1.2.3 Digital Pathology Endpoints

1.2.4 Electronic Clinical Outcome Assessment

1.2.5 Wearable and Physiological Endpoints

1.2.6 Voice, Video and Cognitive Endpoints

1.2.7 Multimodal Endpoints

1.3 Market by Automation Level

1.3.1 Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Automation Level: 2021 vs 2025 vs 2032

1.3.2 AI Quality Control Only

1.3.3 AI Suggestion with Human Finalization

1.3.4 AI Scoring with Exception Review

1.3.5 Fully Automated AI Scoring

1.4 Market by Workflow Scope

1.4.1 Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Workflow Scope: 2021 vs 2025 vs 2032

1.4.2 Data Acquisition Software

1.4.3 Analysis and Scoring Software

1.4.4 Review and Adjudication Software

1.4.5 Integrated Endpoint Platform

1.5 Market by Deployment Model

1.5.1 Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Deployment Model: 2021 vs 2025 vs 2032

1.5.2 Public Cloud SaaS

1.5.3 Private Cloud or VPC

1.5.4 On-Premises Deployment

1.5.5 Hybrid Deployment

1.6 Market by Application

1.6.1 Global AI Clinical Endpoint Assessment Software Market Growth by Application: 2021 vs 2025 vs 2032

1.6.2 Oncology

1.6.3 Neurology and Psychiatry

1.6.4 Cardiovascular and Metabolic Diseases

1.6.5 Respiratory Diseases

1.6.6 Musculoskeletal and Immunology

1.6.7 Other Therapeutic Areas

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Global Growth Trends

2.1 Global AI Clinical Endpoint Assessment Software Market Perspective (2021–2032)

2.2 Global AI Clinical Endpoint Assessment Software Growth Trends by Region

2.2.1 Global AI Clinical Endpoint Assessment Software Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 AI Clinical Endpoint Assessment Software Historic Market Size by Region (2021–2026)

2.2.3 AI Clinical Endpoint Assessment Software Forecasted Market Size by Region (2027–2032)

2.3 AI Clinical Endpoint Assessment Software Market Dynamics

2.3.1 AI Clinical Endpoint Assessment Software Industry Trends

2.3.2 AI Clinical Endpoint Assessment Software Market Drivers

2.3.3 AI Clinical Endpoint Assessment Software Market Challenges

2.3.4 AI Clinical Endpoint Assessment Software Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top AI Clinical Endpoint Assessment Software Players by Revenue

3.1.1 Global Top AI Clinical Endpoint Assessment Software Players by Revenue (2021–2026)

3.1.2 Global AI Clinical Endpoint Assessment Software Revenue Market Share by Players (2021–2026)

3.2 Global Top AI Clinical Endpoint Assessment Software Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by AI Clinical Endpoint Assessment Software Revenue

3.4 Global AI Clinical Endpoint Assessment Software Market Concentration Ratio

3.4.1 Global AI Clinical Endpoint Assessment Software Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by AI Clinical Endpoint Assessment Software Revenue in 2025

3.5 Global Key Players of AI Clinical Endpoint Assessment Software Head Offices and Areas Served

3.6 Global Key Players of AI Clinical Endpoint Assessment Software, Products and Applications

3.7 Global Key Players of AI Clinical Endpoint Assessment Software, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 AI Clinical Endpoint Assessment Software Breakdown Data by Type

4.1 Global AI Clinical Endpoint Assessment Software Historic Market Size by Type (2021–2026)

4.2 Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Type (2027–2032)

5 AI Clinical Endpoint Assessment Software Breakdown Data by Application

5.1 Global AI Clinical Endpoint Assessment Software Historic Market Size by Application (2021–2026)

5.2 Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America AI Clinical Endpoint Assessment Software Market Size (2021–2032)

6.2 North America AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America AI Clinical Endpoint Assessment Software Market Size by Country (2021–2026)

6.4 North America AI Clinical Endpoint Assessment Software Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe AI Clinical Endpoint Assessment Software Market Size (2021–2032)

7.2 Europe AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2021–2026)

7.4 Europe AI Clinical Endpoint Assessment Software Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size (2021–2032)

8.2 Asia-Pacific AI Clinical Endpoint Assessment Software Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Region (2021–2026)

8.4 Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America AI Clinical Endpoint Assessment Software Market Size (2021–2032)

9.2 Latin America AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America AI Clinical Endpoint Assessment Software Market Size by Country (2021–2026)

9.4 Latin America AI Clinical Endpoint Assessment Software Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size (2021–2032)

10.2 Middle East & Africa AI Clinical Endpoint Assessment Software Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2021–2026)

10.4 Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Clario

11.1.1 Clario Company Details

11.1.2 Clario Business Overview

11.1.3 Clario AI Clinical Endpoint Assessment Software Introduction

11.1.4 Clario Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.1.5 Clario Recent Development

11.2 Medidata

11.2.1 Medidata Company Details

11.2.2 Medidata Business Overview

11.2.3 Medidata AI Clinical Endpoint Assessment Software Introduction

11.2.4 Medidata Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.2.5 Medidata Recent Development

11.3 Signant Health

11.3.1 Signant Health Company Details

11.3.2 Signant Health Business Overview

11.3.3 Signant Health AI Clinical Endpoint Assessment Software Introduction

11.3.4 Signant Health Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.3.5 Signant Health Recent Development

11.4 IQVIA

11.4.1 IQVIA Company Details

11.4.2 IQVIA Business Overview

11.4.3 IQVIA AI Clinical Endpoint Assessment Software Introduction

11.4.4 IQVIA Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.4.5 IQVIA Recent Development

11.5 ICON

11.5.1 ICON Company Details

11.5.2 ICON Business Overview

11.5.3 ICON AI Clinical Endpoint Assessment Software Introduction

11.5.4 ICON Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.5.5 ICON Recent Development

11.6 Perceptive

11.6.1 Perceptive Company Details

11.6.2 Perceptive Business Overview

11.6.3 Perceptive AI Clinical Endpoint Assessment Software Introduction

11.6.4 Perceptive Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.6.5 Perceptive Recent Development

11.7 Clinical Ink

11.7.1 Clinical Ink Company Details

11.7.2 Clinical Ink Business Overview

11.7.3 Clinical Ink AI Clinical Endpoint Assessment Software Introduction

11.7.4 Clinical Ink Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.7.5 Clinical Ink Recent Development

11.8 Koneksa

11.8.1 Koneksa Company Details

11.8.2 Koneksa Business Overview

11.8.3 Koneksa AI Clinical Endpoint Assessment Software Introduction

11.8.4 Koneksa Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.8.5 Koneksa Recent Development

11.9 AiCure

11.9.1 AiCure Company Details

11.9.2 AiCure Business Overview

11.9.3 AiCure AI Clinical Endpoint Assessment Software Introduction

11.9.4 AiCure Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.9.5 AiCure Recent Development

11.10 Medable

11.10.1 Medable Company Details

11.10.2 Medable Business Overview

11.10.3 Medable AI Clinical Endpoint Assessment Software Introduction

11.10.4 Medable Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.10.5 Medable Recent Development

11.11 PathAI

11.11.1 PathAI Company Details

11.11.2 PathAI Business Overview

11.11.3 PathAI AI Clinical Endpoint Assessment Software Introduction

11.11.4 PathAI Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.11.5 PathAI Recent Development

11.12 Proscia

11.12.1 Proscia Company Details

11.12.2 Proscia Business Overview

11.12.3 Proscia AI Clinical Endpoint Assessment Software Introduction

11.12.4 Proscia Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.12.5 Proscia Recent Development

11.13 Paige

11.13.1 Paige Company Details

11.13.2 Paige Business Overview

11.13.3 Paige AI Clinical Endpoint Assessment Software Introduction

11.13.4 Paige Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.13.5 Paige Recent Development

11.14 IXICO

11.14.1 IXICO Company Details

11.14.2 IXICO Business Overview

11.14.3 IXICO AI Clinical Endpoint Assessment Software Introduction

11.14.4 IXICO Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.14.5 IXICO Recent Development

11.15 Median Technologies

11.15.1 Median Technologies Company Details

11.15.2 Median Technologies Business Overview

11.15.3 Median Technologies AI Clinical Endpoint Assessment Software Introduction

11.15.4 Median Technologies Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.15.5 Median Technologies Recent Development

11.16 VIDA Diagnostics

11.16.1 VIDA Diagnostics Company Details

11.16.2 VIDA Diagnostics Business Overview

11.16.3 VIDA Diagnostics AI Clinical Endpoint Assessment Software Introduction

11.16.4 VIDA Diagnostics Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.16.5 VIDA Diagnostics Recent Development

11.17 Image Analysis Group

11.17.1 Image Analysis Group Company Details

11.17.2 Image Analysis Group Business Overview

11.17.3 Image Analysis Group AI Clinical Endpoint Assessment Software Introduction

11.17.4 Image Analysis Group Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.17.5 Image Analysis Group Recent Development

11.18 QMENTA

11.18.1 QMENTA Company Details

11.18.2 QMENTA Business Overview

11.18.3 QMENTA AI Clinical Endpoint Assessment Software Introduction

11.18.4 QMENTA Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.18.5 QMENTA Recent Development

11.19 Cambridge Cognition

11.19.1 Cambridge Cognition Company Details

11.19.2 Cambridge Cognition Business Overview

11.19.3 Cambridge Cognition AI Clinical Endpoint Assessment Software Introduction

11.19.4 Cambridge Cognition Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.19.5 Cambridge Cognition Recent Development

11.20 Cogstate

11.20.1 Cogstate Company Details

11.20.2 Cogstate Business Overview

11.20.3 Cogstate AI Clinical Endpoint Assessment Software Introduction

11.20.4 Cogstate Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.20.5 Cogstate Recent Development

11.21 Empatica

11.21.1 Empatica Company Details

11.21.2 Empatica Business Overview

11.21.3 Empatica AI Clinical Endpoint Assessment Software Introduction

11.21.4 Empatica Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.21.5 Empatica Recent Development

11.22 Cumulus Neuroscience

11.22.1 Cumulus Neuroscience Company Details

11.22.2 Cumulus Neuroscience Business Overview

11.22.3 Cumulus Neuroscience AI Clinical Endpoint Assessment Software Introduction

11.22.4 Cumulus Neuroscience Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.22.5 Cumulus Neuroscience Recent Development

11.23 Rune Labs

11.23.1 Rune Labs Company Details

11.23.2 Rune Labs Business Overview

11.23.3 Rune Labs AI Clinical Endpoint Assessment Software Introduction

11.23.4 Rune Labs Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.23.5 Rune Labs Recent Development

11.24 VivoSense

11.24.1 VivoSense Company Details

11.24.2 VivoSense Business Overview

11.24.3 VivoSense AI Clinical Endpoint Assessment Software Introduction

11.24.4 VivoSense Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.24.5 VivoSense Recent Development

11.25 NeuraLight

11.25.1 NeuraLight Company Details

11.25.2 NeuraLight Business Overview

11.25.3 NeuraLight AI Clinical Endpoint Assessment Software Introduction

11.25.4 NeuraLight Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.25.5 NeuraLight Recent Development

11.26 Aural Analytics

11.26.1 Aural Analytics Company Details

11.26.2 Aural Analytics Business Overview

11.26.3 Aural Analytics AI Clinical Endpoint Assessment Software Introduction

11.26.4 Aural Analytics Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.26.5 Aural Analytics Recent Development

11.27 Linus Health

11.27.1 Linus Health Company Details

11.27.2 Linus Health Business Overview

11.27.3 Linus Health AI Clinical Endpoint Assessment Software Introduction

11.27.4 Linus Health Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.27.5 Linus Health Recent Development

11.28 Quibim

11.28.1 Quibim Company Details

11.28.2 Quibim Business Overview

11.28.3 Quibim AI Clinical Endpoint Assessment Software Introduction

11.28.4 Quibim Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.28.5 Quibim Recent Development

11.29 Perspectum

11.29.1 Perspectum Company Details

11.29.2 Perspectum Business Overview

11.29.3 Perspectum AI Clinical Endpoint Assessment Software Introduction

11.29.4 Perspectum Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.29.5 Perspectum Recent Development

11.30 Brainomix

11.30.1 Brainomix Company Details

11.30.2 Brainomix Business Overview

11.30.3 Brainomix AI Clinical Endpoint Assessment Software Introduction

11.30.4 Brainomix Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.30.5 Brainomix Recent Development

11.31 Taimei Technology

11.31.1 Taimei Technology Company Details

11.31.2 Taimei Technology Business Overview

11.31.3 Taimei Technology AI Clinical Endpoint Assessment Software Introduction

11.31.4 Taimei Technology Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.31.5 Taimei Technology Recent Development

11.32 UnionClin

11.32.1 UnionClin Company Details

11.32.2 UnionClin Business Overview

11.32.3 UnionClin AI Clinical Endpoint Assessment Software Introduction

11.32.4 UnionClin Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.32.5 UnionClin Recent Development

11.33 XincereMed

11.33.1 XincereMed Company Details

11.33.2 XincereMed Business Overview

11.33.3 XincereMed AI Clinical Endpoint Assessment Software Introduction

11.33.4 XincereMed Revenue in AI Clinical Endpoint Assessment Software Business (2021–2026)

11.33.5 XincereMed Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Medical Imaging Endpoints

Table 3. Key Players of Digital Pathology Endpoints

Table 4. Key Players of Electronic Clinical Outcome Assessment

Table 5. Key Players of Wearable and Physiological Endpoints

Table 6. Key Players of Voice, Video and Cognitive Endpoints

Table 7. Key Players of Multimodal Endpoints

Table 8. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Automation Level (US$ Million): 2021 vs 2025 vs 2032

Table 9. Key Players of AI Quality Control Only

Table 10. Key Players of AI Suggestion with Human Finalization

Table 11. Key Players of AI Scoring with Exception Review

Table 12. Key Players of Fully Automated AI Scoring

Table 13. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Workflow Scope (US$ Million): 2021 vs 2025 vs 2032

Table 14. Key Players of Data Acquisition Software

Table 15. Key Players of Analysis and Scoring Software

Table 16. Key Players of Review and Adjudication Software

Table 17. Key Players of Integrated Endpoint Platform

Table 18. Global AI Clinical Endpoint Assessment Software Market Size Growth Rate by Deployment Model (US$ Million): 2021 vs 2025 vs 2032

Table 19. Key Players of Public Cloud SaaS

Table 20. Key Players of Private Cloud or VPC

Table 21. Key Players of On-Premises Deployment

Table 22. Key Players of Hybrid Deployment

Table 23. Global AI Clinical Endpoint Assessment Software Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 24. Global AI Clinical Endpoint Assessment Software Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 25. Global AI Clinical Endpoint Assessment Software Market Size by Region (US$ Million), 2021–2026

Table 26. Global AI Clinical Endpoint Assessment Software Market Share by Region (2021–2026)

Table 27. Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Region (US$ Million), 2027–2032

Table 28. Global AI Clinical Endpoint Assessment Software Market Share by Region (2027–2032)

Table 29. AI Clinical Endpoint Assessment Software Market Trends

Table 30. AI Clinical Endpoint Assessment Software Market Drivers

Table 31. AI Clinical Endpoint Assessment Software Market Challenges

Table 32. AI Clinical Endpoint Assessment Software Market Restraints

Table 33. Global AI Clinical Endpoint Assessment Software Revenue by Players (US$ Million), 2021–2026

Table 34. Global AI Clinical Endpoint Assessment Software Market Share by Players (2021–2026)

Table 35. Global Top AI Clinical Endpoint Assessment Software Players by Tier (Tier 1, Tier 2, and Tier 3), based on AI Clinical Endpoint Assessment Software Revenue, 2025

Table 36. Ranking of Global Top AI Clinical Endpoint Assessment Software Companies by Revenue (US$ Million) in 2025

Table 37. Global 5 Largest Players Market Share by AI Clinical Endpoint Assessment Software Revenue (CR5 and HHI), 2021–2026

Table 38. Global Key Players of AI Clinical Endpoint Assessment Software, Headquarters and Area Served

Table 39. Global Key Players of AI Clinical Endpoint Assessment Software, Products and Applications

Table 40. Global Key Players of AI Clinical Endpoint Assessment Software, Date of General Availability (GA)

Table 41. Mergers and Acquisitions, Expansion Plans

Table 42. Global AI Clinical Endpoint Assessment Software Market Size by Type (US$ Million), 2021–2026

Table 43. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2021–2026)

Table 44. Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Type (US$ Million), 2027–2032

Table 45. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Type (2027–2032)

Table 46. Global AI Clinical Endpoint Assessment Software Market Size by Application (US$ Million), 2021–2026

Table 47. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2021–2026)

Table 48. Global AI Clinical Endpoint Assessment Software Forecasted Market Size by Application (US$ Million), 2027–2032

Table 49. Global AI Clinical Endpoint Assessment Software Revenue Market Share by Application (2027–2032)

Table 50. North America AI Clinical Endpoint Assessment Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 51. North America AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2021–2026

Table 52. North America AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2027–2032

Table 53. Europe AI Clinical Endpoint Assessment Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Europe AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2021–2026

Table 55. Europe AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2027–2032

Table 56. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 57. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Region (US$ Million), 2021–2026

Table 58. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size by Region (US$ Million), 2027–2032

Table 59. Latin America AI Clinical Endpoint Assessment Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 60. Latin America AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2021–2026

Table 61. Latin America AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2027–2032

Table 62. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 63. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2021–2026

Table 64. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size by Country (US$ Million), 2027–2032

Table 65. Clario Company Details

Table 66. Clario Business Overview

Table 67. Clario AI Clinical Endpoint Assessment Software Product

Table 68. Clario Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 69. Clario Recent Development

Table 70. Medidata Company Details

Table 71. Medidata Business Overview

Table 72. Medidata AI Clinical Endpoint Assessment Software Product

Table 73. Medidata Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 74. Medidata Recent Development

Table 75. Signant Health Company Details

Table 76. Signant Health Business Overview

Table 77. Signant Health AI Clinical Endpoint Assessment Software Product

Table 78. Signant Health Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 79. Signant Health Recent Development

Table 80. IQVIA Company Details

Table 81. IQVIA Business Overview

Table 82. IQVIA AI Clinical Endpoint Assessment Software Product

Table 83. IQVIA Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 84. IQVIA Recent Development

Table 85. ICON Company Details

Table 86. ICON Business Overview

Table 87. ICON AI Clinical Endpoint Assessment Software Product

Table 88. ICON Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 89. ICON Recent Development

Table 90. Perceptive Company Details

Table 91. Perceptive Business Overview

Table 92. Perceptive AI Clinical Endpoint Assessment Software Product

Table 93. Perceptive Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 94. Perceptive Recent Development

Table 95. Clinical Ink Company Details

Table 96. Clinical Ink Business Overview

Table 97. Clinical Ink AI Clinical Endpoint Assessment Software Product

Table 98. Clinical Ink Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 99. Clinical Ink Recent Development

Table 100. Koneksa Company Details

Table 101. Koneksa Business Overview

Table 102. Koneksa AI Clinical Endpoint Assessment Software Product

Table 103. Koneksa Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 104. Koneksa Recent Development

Table 105. AiCure Company Details

Table 106. AiCure Business Overview

Table 107. AiCure AI Clinical Endpoint Assessment Software Product

Table 108. AiCure Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 109. AiCure Recent Development

Table 110. Medable Company Details

Table 111. Medable Business Overview

Table 112. Medable AI Clinical Endpoint Assessment Software Product

Table 113. Medable Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 114. Medable Recent Development

Table 115. PathAI Company Details

Table 116. PathAI Business Overview

Table 117. PathAI AI Clinical Endpoint Assessment Software Product

Table 118. PathAI Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 119. PathAI Recent Development

Table 120. Proscia Company Details

Table 121. Proscia Business Overview

Table 122. Proscia AI Clinical Endpoint Assessment Software Product

Table 123. Proscia Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 124. Proscia Recent Development

Table 125. Paige Company Details

Table 126. Paige Business Overview

Table 127. Paige AI Clinical Endpoint Assessment Software Product

Table 128. Paige Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 129. Paige Recent Development

Table 130. IXICO Company Details

Table 131. IXICO Business Overview

Table 132. IXICO AI Clinical Endpoint Assessment Software Product

Table 133. IXICO Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 134. IXICO Recent Development

Table 135. Median Technologies Company Details

Table 136. Median Technologies Business Overview

Table 137. Median Technologies AI Clinical Endpoint Assessment Software Product

Table 138. Median Technologies Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 139. Median Technologies Recent Development

Table 140. VIDA Diagnostics Company Details

Table 141. VIDA Diagnostics Business Overview

Table 142. VIDA Diagnostics AI Clinical Endpoint Assessment Software Product

Table 143. VIDA Diagnostics Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 144. VIDA Diagnostics Recent Development

Table 145. Image Analysis Group Company Details

Table 146. Image Analysis Group Business Overview

Table 147. Image Analysis Group AI Clinical Endpoint Assessment Software Product

Table 148. Image Analysis Group Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 149. Image Analysis Group Recent Development

Table 150. QMENTA Company Details

Table 151. QMENTA Business Overview

Table 152. QMENTA AI Clinical Endpoint Assessment Software Product

Table 153. QMENTA Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 154. QMENTA Recent Development

Table 155. Cambridge Cognition Company Details

Table 156. Cambridge Cognition Business Overview

Table 157. Cambridge Cognition AI Clinical Endpoint Assessment Software Product

Table 158. Cambridge Cognition Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 159. Cambridge Cognition Recent Development

Table 160. Cogstate Company Details

Table 161. Cogstate Business Overview

Table 162. Cogstate AI Clinical Endpoint Assessment Software Product

Table 163. Cogstate Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 164. Cogstate Recent Development

Table 165. Empatica Company Details

Table 166. Empatica Business Overview

Table 167. Empatica AI Clinical Endpoint Assessment Software Product

Table 168. Empatica Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 169. Empatica Recent Development

Table 170. Cumulus Neuroscience Company Details

Table 171. Cumulus Neuroscience Business Overview

Table 172. Cumulus Neuroscience AI Clinical Endpoint Assessment Software Product

Table 173. Cumulus Neuroscience Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 174. Cumulus Neuroscience Recent Development

Table 175. Rune Labs Company Details

Table 176. Rune Labs Business Overview

Table 177. Rune Labs AI Clinical Endpoint Assessment Software Product

Table 178. Rune Labs Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 179. Rune Labs Recent Development

Table 180. VivoSense Company Details

Table 181. VivoSense Business Overview

Table 182. VivoSense AI Clinical Endpoint Assessment Software Product

Table 183. VivoSense Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 184. VivoSense Recent Development

Table 185. NeuraLight Company Details

Table 186. NeuraLight Business Overview

Table 187. NeuraLight AI Clinical Endpoint Assessment Software Product

Table 188. NeuraLight Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 189. NeuraLight Recent Development

Table 190. Aural Analytics Company Details

Table 191. Aural Analytics Business Overview

Table 192. Aural Analytics AI Clinical Endpoint Assessment Software Product

Table 193. Aural Analytics Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 194. Aural Analytics Recent Development

Table 195. Linus Health Company Details

Table 196. Linus Health Business Overview

Table 197. Linus Health AI Clinical Endpoint Assessment Software Product

Table 198. Linus Health Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 199. Linus Health Recent Development

Table 200. Quibim Company Details

Table 201. Quibim Business Overview

Table 202. Quibim AI Clinical Endpoint Assessment Software Product

Table 203. Quibim Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 204. Quibim Recent Development

Table 205. Perspectum Company Details

Table 206. Perspectum Business Overview

Table 207. Perspectum AI Clinical Endpoint Assessment Software Product

Table 208. Perspectum Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 209. Perspectum Recent Development

Table 210. Brainomix Company Details

Table 211. Brainomix Business Overview

Table 212. Brainomix AI Clinical Endpoint Assessment Software Product

Table 213. Brainomix Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 214. Brainomix Recent Development

Table 215. Taimei Technology Company Details

Table 216. Taimei Technology Business Overview

Table 217. Taimei Technology AI Clinical Endpoint Assessment Software Product

Table 218. Taimei Technology Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 219. Taimei Technology Recent Development

Table 220. UnionClin Company Details

Table 221. UnionClin Business Overview

Table 222. UnionClin AI Clinical Endpoint Assessment Software Product

Table 223. UnionClin Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 224. UnionClin Recent Development

Table 225. XincereMed Company Details

Table 226. XincereMed Business Overview

Table 227. XincereMed AI Clinical Endpoint Assessment Software Product

Table 228. XincereMed Revenue in AI Clinical Endpoint Assessment Software Business (US$ Million), 2021–2026

Table 229. XincereMed Recent Development

Table 230. Research Programs/Design for This Report

Table 231. Key Data Information from Secondary Sources

Table 232. Key Data Information from Primary Sources

Table 233. Authors List of This Report

List of Figures

Figure 1. AI Clinical Endpoint Assessment Software Picture

Figure 2. Global AI Clinical Endpoint Assessment Software Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global AI Clinical Endpoint Assessment Software Market Share by Type: 2025 vs 2032

Figure 4. Medical Imaging Endpoints Features

Figure 5. Digital Pathology Endpoints Features

Figure 6. Electronic Clinical Outcome Assessment Features

Figure 7. Wearable and Physiological Endpoints Features

Figure 8. Voice, Video and Cognitive Endpoints Features

Figure 9. Multimodal Endpoints Features

Figure 10. Global AI Clinical Endpoint Assessment Software Market Size Comparison by Automation Level (US$ Million), 2021–2032

Figure 11. AI Quality Control Only Features

Figure 12. AI Suggestion with Human Finalization Features

Figure 13. AI Scoring with Exception Review Features

Figure 14. Fully Automated AI Scoring Features

Figure 15. Global AI Clinical Endpoint Assessment Software Market Size Comparison by Workflow Scope (US$ Million), 2021–2032

Figure 16. Data Acquisition Software Features

Figure 17. Analysis and Scoring Software Features

Figure 18. Review and Adjudication Software Features

Figure 19. Integrated Endpoint Platform Features

Figure 20. Global AI Clinical Endpoint Assessment Software Market Size Comparison by Deployment Model (US$ Million), 2021–2032

Figure 21. Public Cloud SaaS Features

Figure 22. Private Cloud or VPC Features

Figure 23. On-Premises Deployment Features

Figure 24. Hybrid Deployment Features

Figure 25. Global AI Clinical Endpoint Assessment Software Market Size by Application (US$ Million), 2021–2032

Figure 26. Global AI Clinical Endpoint Assessment Software Market Share by Application: 2025 vs 2032

Figure 27. Oncology Case Studies

Figure 28. Neurology and Psychiatry Case Studies

Figure 29. Cardiovascular and Metabolic Diseases Case Studies

Figure 30. Respiratory Diseases Case Studies

Figure 31. Musculoskeletal and Immunology Case Studies

Figure 32. Other Therapeutic Areas Case Studies

Figure 33. AI Clinical Endpoint Assessment Software Report Years Considered

Figure 34. Global AI Clinical Endpoint Assessment Software Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 35. Global AI Clinical Endpoint Assessment Software Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 36. Global AI Clinical Endpoint Assessment Software Market Share by Region: 2025 vs 2032

Figure 37. Global AI Clinical Endpoint Assessment Software Market Share by Players in 2025

Figure 38. Global AI Clinical Endpoint Assessment Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 39. The Top 10 and 5 Players Market Share by AI Clinical Endpoint Assessment Software Revenue in 2025

Figure 40. North America AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. North America AI Clinical Endpoint Assessment Software Market Share by Country (2021–2032)

Figure 42. United States AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Canada AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Europe AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Europe AI Clinical Endpoint Assessment Software Market Share by Country (2021–2032)

Figure 46. Germany AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. France AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. U.K. AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Italy AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Russia AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Ireland AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Asia-Pacific AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Asia-Pacific AI Clinical Endpoint Assessment Software Market Share by Region (2021–2032)

Figure 54. China AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Japan AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. South Korea AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Southeast Asia AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. India AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Australia & New Zealand AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 60. Latin America AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 61. Latin America AI Clinical Endpoint Assessment Software Market Share by Country (2021–2032)

Figure 62. Mexico AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 63. Brazil AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 64. Middle East & Africa AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 65. Middle East & Africa AI Clinical Endpoint Assessment Software Market Share by Country (2021–2032)

Figure 66. Israel AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 67. Saudi Arabia AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 68. UAE AI Clinical Endpoint Assessment Software Market Size YoY Growth (US$ Million), 2021–2032

Figure 69. Clario Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 70. Medidata Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 71. Signant Health Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 72. IQVIA Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 73. ICON Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 74. Perceptive Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 75. Clinical Ink Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 76. Koneksa Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 77. AiCure Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 78. Medable Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 79. PathAI Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 80. Proscia Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 81. Paige Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 82. IXICO Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 83. Median Technologies Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 84. VIDA Diagnostics Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 85. Image Analysis Group Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 86. QMENTA Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 87. Cambridge Cognition Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 88. Cogstate Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 89. Empatica Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 90. Cumulus Neuroscience Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 91. Rune Labs Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 92. VivoSense Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 93. NeuraLight Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 94. Aural Analytics Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 95. Linus Health Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 96. Quibim Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 97. Perspectum Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 98. Brainomix Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 99. Taimei Technology Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 100. UnionClin Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 101. XincereMed Revenue Growth Rate in AI Clinical Endpoint Assessment Software Business (2021–2026)

Figure 102. Bottom-up and Top-down Approaches for This Report

Figure 103. Data Triangulation

Figure 104. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI Clinical Endpoint Assessment Software market? zhanKai

The top companies in the global AI Clinical Endpoint Assessment Software market are Clario、Medidata、Signant Health.

What was the global market size of AI Clinical Endpoint Assessment Software in 2032? shouQi

What was the global market size of AI Clinical Endpoint Assessment Software in 2026? shouQi

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global AI Clinical Endpoint Assessment Software market size from 2026 to 2032? shouQi

Related Reports

Global AI Clinical Endpoint Assessment Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Clinical Endpoint Assessment Software market is projected to grow from US$ 1148 million in 2025 to US$ 3581 million by 2032, at a CAGR of 17.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-18
Pages: 217
USD 4900.00
(Single User License)
AI Clinical Endpoint Assessment Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Clinical Endpoint Assessment Software was estimated to be worth US$ 1148 million in 2025 and is projected to reach US$ 3581 million, growing at a CAGR of 17.6% from 2026 to 2032.
Published Date: 2026-07-18
Pages: 198
USD 3950.00
(Single User License)
Global AI Clinical Endpoint Assessment Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Clinical Endpoint Assessment Software market size was US$ 1148 million in 2025 and is forecast to reach a readjusted size of US$ 3581 million by 2032 with a CAGR of 17.6% during the forecast period 2026-2032.
Published Date: 2026-07-18
Pages: 204
USD 4250.00
(Single User License)

Global AI Clinical Endpoint Assessment Software Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Clinical Endpoint Assessment Software market is projected to grow from US$ 1148 million in 2025 to US$ 3581 million by 2032, at a CAGR of 17.6% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-18
Pages: 217
USD 4900.00 (Single User License)
AI Clinical Endpoint Assessment Software - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Clinical Endpoint Assessment Software was estimated to be worth US$ 1148 million in 2025 and is projected to reach US$ 3581 million, growing at a CAGR of 17.6% from 2026 to 2032.
Published: 2026-07-18
Pages: 198
USD 3950.00 (Single User License)
Global AI Clinical Endpoint Assessment Software Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Clinical Endpoint Assessment Software market size was US$ 1148 million in 2025 and is forecast to reach a readjusted size of US$ 3581 million by 2032 with a CAGR of 17.6% during the forecast period 2026-2032.
Published: 2026-07-18
Pages: 204
USD 4250.00 (Single User License)